Co-SponSored By Promedica International and Cedars-Sinai Medical Center in cooperation with the California

Chapter of the American College of Cardiology, the British Cardiovascular Society, the California Society of Thoracic

Surgeons, the American College of Cardiology Foundation, the American Heart Association, and the International

Academy of Cardiology

23rd Annual Meeting of the California ACC

program direCTorS: Raj Makkar, MD, FACC,

P.K. Shah, MD, FACC, Alfredo Trento, MD, John G. Harold, MD, MACC,

Jon Kobashigawa, MD, FACC, Gregory P. Fontana, MD, FACC,

William Bommer, MD, FACC

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

The Twelfth in the Series • September 21 & 22, 2012The Beverly Hills Hotel – Beverly Hills, California

: : Aortic Stenting: : Aortic Surgery: : Arrhythmias: : Atherosclerosis: : Anti-thrombotic Therapy: : Carotid Stenting and

Surgery: : Cell Therapy

: : Congenital Heart Disease in Adults

: : Congestive Heart Failure: : Coronary Surgery: : Drug Eluting Stents: : Healthcare Policy: : Imaging: : Minimally Invasive Surgery

: : New Devices: Cardiac Resynchronization, Heart Failure Monitors

: : Percutaneous Valve Repair and Replacement

: : Stem Cell Therapy: : Valvular Heart Disease: : Other

PRO G R A M DE S C R I P T ION

We are proud to be celebrating the twelfth annual Controversies and Advances in the Treatment of Cardiovascular Disease symposium this year! The two-day scientific program will offer realistic views on many controversial issues in cardiovascular disease today. Session topics will include imaging, hypertension, stem cells, heart failure, coronary artery disease, transcatheter aortic valve replacement, mitral valve disease, and cardioembolic stroke.

Sessions will include a combination of debates, keynote lectures, crossfires, and roundtable discussions. A faculty of internationally known leaders in the field has been invited to share their knowledge and experiences with complex and controversial cases.

TA RG E T AU DI E NC E

The conference is designed for cardiologists, cardiovascular and thoracic surgeons, interventional cardiologists, perfusionists, ICU nurses, technicians and those involved in the diagnosis, treatment and care of individuals with controversial and complex cases of cardiac disease.

L E A R N I NG OBJ E C T I V E S

Upon completion of this course, participants should be able to:

C A L L FOR A B ST R AC TS

Submissions of original abstracts are being accepted and will be considered for oral presentation and poster display when submitted online at www.promedicacme.com.

The international abstract Competition will be held Thursday, September 20, 2012 from 6:00 – 8:00 pm.

Deadline for Abstract Submissions: August 24, 2012

Abstract Categories

: : Evaluate different imaging modalities and their treatment implications in the diagnosis of cardiovascular diseases.

: : Understand the benefits and limitations of thiazide diuretics, the Cardiac J Curve, and renal denervation in the treatment of hypertension.

: : Learn the data from ongoing clinical trials in cell therapy for heart disease, and discuss new trials and their potential.

: : Discuss alternatives to the treatment of end stage heart disease, including organ engineering, xenotransplantation, and acquired tolerance for transplant achieved with bone marrow stem cells.

: : Measure the benefits and limitations of current approaches to medical therapy for

end stage heart disease, including stem cell therapy, mechanical circulatory support, individualized medicine, and the clinical trials for new therapies.

: : Compare and contrast statin safety and efficacy in the treatment of coronary artery disease.

: : Understand the controversies and debates surrounding transcatheter aortic valve replacement.

: : Learn the pathophysiology of mitral regurgitation and compare and contrast medical, interventional, and surgical therapies.

: : Evaluate the debates in stroke prevention for atrial fibrillation patients through medical, interventional, and surgical treatments.

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

The Twelfth in the Series • September 21 & 22, 2012

K EY NOT E SPE A K E R S

C. Noel Bairey Merz, MD, FACC

Dr. Bairey Merz holds the Women's Guild Chair in Women's Health, and is Director of the Barbara Streisand Heart Center as well as the Preventative and Rehabilitative Cardiac Center at Cedars-Sinai Medical Center. She also is Professor of Medicine at Cedars-Sinai. Dr. Bairey Merz's research interests include women and heart disease, mental stress and heart disease, the role of exercise and stress management in reversing disease, and the role of nutrition in heart disease. Currently, she is chair of the National Institutes of Health (NIH)-sponsored WISE (Women's Ischemic Syndrome Evaluation) initiative, which is investigating potential methods for more effective diagnosis and evaluation of coronary artery disease in women.

Anthony N. DeMaria, MD, MACC

Dr. DeMaria is the Judith and Jack White Chair in Cardiology and founding director of the Sulpizio Cardiovascular Center at UCSD. He regularly participates in trials involving non-invasive methods to diagnose and treat heart disease. Dr. DeMaria has received numerous awards and is listed in The Best Doctors in America. He served as a member of the Subspecialty Board on Cardiovascular Disease for the American Board of Internal Medicine from 1991 to 1997. He is the Editor in Chief of the Journal of American College of Cardiology and Echocardiography and he serves on the editorial boards and acts as editorial consultant for almost 30 medical journals.

David R. Holmes, Jr., MD, MACC

Due to his many academic contributions and dedication to cardiovascular care, Dr. Holmes is the immediate past president of the American College of Cardiology. Over the years, Dr. Holmes has been recognized with numerous awards, including the ACC Distinguished Scientist Award (Clinical Domain), has published extensively and serves on the editorial boards of many journals. He is the Edward W. and Betty Knight Scripps Professor in Cardiovascular Medicine at the Mayo Clinic College of Medicine in Rochester, Minnesota.

Martin B. Leon, MD, FACC

Dr. Leon is the Director and CEO of the Cardiovascular Research Foundation and Professor of Medicine at Columbia University Medical Center as well as the Associate Director of the Center for Interventional Vascular Therapy at CUMC, and a practicing interventional cardiologist at New York-Presbyterian Hospsital. He has served as principal investigator for over 50 clinical trials that have helped shape the field of interventional cardiovascular medicine, including STRESS, STARS, Gamma 1, SIRIUS, ENDEAVOR, and most recently, the PARTNER trial.

Michael J. Mack, MD, FACC

Long recognized as a thought-leader in the fields of percutaneous valve therapy and minimally invasive cardiothoracic surgery, Dr. Mack is the immediate Past President of the Society of Thoracic Surgeons. He also serves as Medical Director of Cardiovascular Surgery for the Baylor Healthcare System, is Chairman of the Heart Hospital, Baylor Plano Research Center and is Chairman of the Cardiopulmonary Research Science & Technology Institute (CRSTI).

Program Directors

Raj Makkar, MD, FACCCedars-Sinai Heart InstituteLos Angeles, CA

P.K. Shah, MD, FACCCedars-Sinai Heart InstituteLos Angeles, CA

Alfredo Trento, MDCedars-Sinai Heart InstituteLos Angeles, CA

John G. Harold, MD, MACCCedars-Sinai Heart InstituteLos Angeles, CA

Jon Kobashigawa, MD, FACCCedars-Sinai Heart InstituteLos Angeles, CA

William Bommer, MD, FACCUniversity of California, DavisSacramento, CA

Honorary Program Director

Gregory P. Fontana, MD, FACCLenox Hill HospitalNew York, NY

Local Faculty

C. Noel Bairey Merz, MD, FACC

Daniel S. Berman, MD, FACC

Bojan Cercek, MD, PhD, FACC

Wen Cheng, MD

Sumeet Chugh, MD, FACC

Kuang-Yuh Chyu, MD, PhD

Lawrence S.C. Czer, MD, FACC

Suhail Y. Dohad, MD, FACC

Neal Eigler, MD, FACC

Fardad Esmailian, MD, FACC

James S. Forrester, MD, FACC

Bruce L. Gewertz, MD

Swaminatha Gurudevan, MD, FACC

Michele Hamilton, MD, FACC

Hasan Jilaihawi, MD

Saibal Kar, MD, FACC

Ronald P. Karlsberg, MD, FACC

Robert M. Kass, MD

Ali Khoynezhad, MD, PhD, FACC

Asher Kimchi, MD, FACC

Michelle Kittleson, MD, PhD, FACC

Norman E. Lepor, MD, FACC

Frank Litvack, MD, FACC

Patrick D. Lyden, MD

Hooman Madyoon, MD, FACC

Eduardo Marbán, MD, PhD, FACC

James K. Min, MD, FACC

Jaime D. Moriguchi, MD, FACC

Jignesh K. Patel, MD, PhD, FACC

Daniel J. Rader, MD

Danny Ramzy, MD, PhD, FACC

Bruce A. Samuels, MD, FACC

Ernst Schwarz, MD, PhD, FACC

Michael Shehata, MD, FACC

Takahiro Shiota, MD, FACC

Robert J. Siegel, MD, FACC

Charles D. Swerdlow, MD, FACC

Ronald G. Victor, MD, FACC

Guest Faculty

Ezra A. Amsterdam, MD, FACCUniversity of California, DavisSacramento, CA

Steven F. Bolling, MD, FACCUniversity of MichiganAnn Arbor, MI

Matthew J. Budoff, MD, FACCUniversity of California, Los AngelesDavid Geffen School of MedicineTorrance, CA

Vito M. Campese, MDUniversity of Southern California Keck School of MedicineLos Angeles, CA

Blase A. Carabello, MD, FACCHouston Veterans Affairs Medical Center Houston, TX

Anson Cheung, MDSt. Paul's HospitalVancouver, Canada

W. Randolph Chitwood, Jr., MD, FACCEast Carolina University Brody School of MedicineGreenville, NC

David J. Cohen, MD, MScSt. Luke’s Mid America Heart InstituteKansas City, MO

Jack G. Copeland III, MD, FACCUniversity of California, San DiegoSan Diego, CA

Keith D. Dawkins, MD, FACCBoston Scientific CorporationNatick, MA

Anthony N. Demaria, MD, MACCUniversity of California, San Diego Medical CenterSan Diego, CA

Marcelo F. Di Carli, MD, FACCBrigham and Women's HospitalBoston, MA

Faculty

Philip J. EbelingSt. Jude Medical Maple Grove, MN

William Fearon, MD, FACCStanford School of MedicineStanford, CA

Ted Feldman, MD, FACCEvanston HospitalEvanston, IL

Gregg C. Fonarow, MD, FACCUniversity of California, Los AngelesDavid Geffen School of MedicineLos Angeles, CA

Chip HanceAbbott VascularSanta Clara, CA

Joshua M. Hare, MD, FACCUniversity of Miami Health SystemMiami, FL

Robert C. Hendel, MD, FACCUniversity of Miami School of MedicineMiami, FL

Timothy D. Henry, MD, FACCMinneapolis Heart Institute FoundationMinneapolis, MN

David R. Holmes, Jr., MD, FACCMayo ClinicRochester, MN

Scott HuennekensVolcano CorporationSan Diego, CA

Dipti Itchhaporia, MD, FACCNewport Coast CardiologyNewport Beach, CA

Samir Kapadia, MD, FACCCleveland ClinicCleveland, OH

Norman M. Kaplan, MDUT Southwestern Medical CenterDallas, TX

Jonathon A. Leipsic, MDSt. Paul's HospitalVancouver, Canada

Martin B. Leon, MD, FACCColumbia University Medical CenterNew York, NY

Joseph R. Leventhal, MDNorthwestern Memorial HospitalChicago, IL

Michael J. Mack, MD, FACCThe Heart Hospital Baylor PlanoPlano, TX

James B. McClurken, MD, FACCTemple University School of MedicinePhiladelphia, PA

Franz Messerli, MD, FACCSt. Luke's-Roosevelt Hospital CenterNew York, NY

Jeffrey W. Moses, MD, FACCColumbia University Medical CenterNew York, NY

David E. Newby, MD, PhDUniversity of EdinburghEdinburgh, United Kingdom

Manesh R. Patel, MD, FACCDuke UniversityDurham, NC

Jeffrey L. Platt, MDUniversity of MichiganAnn Arbor, MI

Jeffrey J. Popma, MD, FACCBeth Israel Deaconess Medical CenterBoston, MA

Subha V. Raman, MD, FACCThe Ohio State UniversityColumbus, OH

Michael J. Reardon, MD, FACCMethodist DeBakey Heart & Vascular CenterHouston, TX

Rita F. Redberg, MD, MSc, FACCUniversity of California, San Francisco Medical CenterSan Francisco, CAMaurice E. Sarano, MDMayo ClinicRochester, MN

Leslee J. Shaw, PhD, FACCEmory University School of MedicineAtlanta, GA

Charles A. Simonton, MD, FACCAbbott VascularSanta Clara, CA

Gregg W. Stone, MD, FACCColumbia UniversityCardiac Research FoundationNew York, NY

Doris A. Taylor, PhD, FACCTexas Heart InstituteHouston, TX

Paul S. Teirstein, MD, FACCScripps ClinicLa Jolla, CA

Martyn R. Thomas, MDSt. Thomas' HospitalLondon, United Kingdom

John G. Webb, MD, FACCSt. Paul’s HospitalVancouver, Canada

Brian K. Whisenant, MD, FACCIntermountain Medical CenterMurray, UT

Larry WoodEdwards LifesciencesIrvine, CA

Andreas Zeiher, MDJW Goethe UniversityFrankfurt, Germany

William A. Zoghbi, MD, FACCMethodist DeBakey Heart & Vascular Center Houston, TX

Preliminary Scientific Program

September 20, 2012

6:00 – 8:00 PM Moderated Oral Abstract SessionModerators: Wen Cheng, MD Swaminatha Gurudevan, MD, FACC Danny Ramzy, MD, PhD, FACC Hooman Madyoon, MD, FACC

September 21, 2012Welcome Address

ACC and STS California Chapter UpdateJohn G. Harold, MD, MACC Dipti Itchhaporia, MD, FACC William Bommer, MD, FACC Jeffrey Milliken, MD

SESSION I: IMAGINGModerators: Daniel Berman, MD, FACC James K. Min, MD, FACC

Treatment Implications of. . .

Cardiac CT for Transcatheter Aortic Valve Replacement Jonathon A. Leipsic, MD

Cardiac PET for Absolute Myocardial Blood FlowMarcelo F. Di Carli, MD, FACC

Coronary CT Angiography for Non-invasive Fractional Flow ReserveJames K. Min, MD, FACC

Cardiac Magnetic Resonance for Intramyocardial Hemorrhage in the Post-MI SettingSubha V. Raman, MD, FACC

DEBATE: Management of CAD in the Setting of Multiple Discordant Non- Invasive Findings: Invasive or Medically Based Approach?: : Invasive Paul S. Teirstein, MD, FACC

: : Medically Manesh R. Patel, MD, FACC

DEBATE: For the Low-to-Intermediate Risk Patient with Acute Chest Pain, Coronary CT Angiography Should be the Standard of Care in the Emergency Department: : Pro Jeffrey W. Moses, MD, FACC : : Con Ezra A. Amsterdam, MD, FACC

DEBATE: Invasive Coronary Angiography and Fractional Flow Reserve Should Supplant the Need for Stress Testing with Imaging: : Pro Jeffrey W. Moses, MD, FACC

: : Con Robert C. Hendel, MD, FACC

DEBATE: A Nuclear Stress Test is Warranted for All Patients with a Significantly Elevated Coronary Calcium Score: : Pro Leslee J. Shaw, PhD, FACC

: : Con Matthew J. Budoff, MD, FACC

Getting to the Heart with Anti-matterDavid E. Newby, MD, PhD

Keynote LectureWomen and Heart Disease Beyond Hype: Hard Facts and Practical SolutionsC. Noel Bairey Merz, MD, FACC

SESSION II: HYPERTENSIONModerators: Ronald C. Victor, MD, FACC Franz H. Messerli, MD, FACC

DEBATE: Thiazide Diuretics: Friend or Foe?: : Pro Norman M. Kaplan, MD

: : Con Franz H. Messerli, MD, FACC

DEBATE: The Cardiac J Curve: Fact or Fiction?: : The Cardiac J Curve Franz H. Messerli, MD, FACC

: : Avoiding the J Curve in Treatment of Hypertension in the Elderly

Norman M. Kaplan, MD

: : Counter Argument Ronald G. Victor, MD, FACC

DEBATE: Renal Denervation: Hope or Hype?: : The Premise Vito M. Campese, MD

: : The Promise Daniel J. Rader, MD

: : Potential Limitations Ronald G. Victor, MD, FACC

SESSION III: STEM CELLS

Bone Marrow Cell Experience and BAMIAndreas Zeiher, MD

MSCsJoshua M. Hare, MD, FACC

CADUCEUS and BeyondEduardo Marbán, MD, PhD, FACC

Ongoing and New Clinical Trials in Cell TherapyTimothy D. Henry, MD, FACC

SESSION IV: ALTERNATIVES TO THE TREATMENT OF END STAGE HEART DISEASEModerators: Jon Kobashigawa, MD, FACC Michele Hamilton, MD, FACC

Organ Engineering Doris A. Taylor, PhD, FACC

XenotransplantationJeffrey L. Platt, MD

Acquired Tolerance with Bone Marrow Stem Cells and Organ TransplantJoseph R. Leventhal, MD

Mechanical Circulatory Support DevicesJack G. Copeland III, MD, FACC

DEBATE: : : Individualized Medicine Jignesh K. Patel, MD, PhD, FACC

: : Clinical Trials for New Therapies

Gregg C. Fonarow, MD, FACC

Roundtable Discussion

Rebuttal & Recap

September 22, 2012SESSION V: CORONARY ARTERY DISEASEModerators: James S. Forrester, MD, FACC Gregg W. Stone, MD, FACC

DEBATE: Statins in Coronary Artery Disease: : Overused? Rita F. Redberg, MD, MSc, FACC

: : Safe and Evidence Abounds P.K. Shah, MD, FACC

Multivessel Stable Coronary Artery Disease: A Broad View of the Clinical Evidence: : An Interventionalist’s

Perspective David R. Holmes, Jr., MD, FACC

: : A Surgeon’s Perspective Michael J. Mack, MD, FACC

SESSION VI: TAVR

Keynote LectureTranscatheter Aortic Valve Replacement: What A Decade It Has Been!Martin B. Leon, MD, FACC

Keynote Lecture New Device Regulatory and Reimbursement Challenges Collaboration is The Key to Success: TAVR, A Case in Point: : An Interventionalist’s

Perspective David R. Holmes, Jr., MD, FACC

: : A Surgeon’s Perspective Michael J. Mack, MD, FACC

TAVR – UNITED STATES

United States Sapien ValveMartin B. Leon, MD, FACC

United States CoreValveJeffrey J. Popma, MD, FACC

TAVR – INTERNATIONAL

Next Generation ValvesJohn G. Webb, MD, FACC

Facilitating Technology: E- Sheath, Distal Embolic ProtectionJohn G. Webb, MD, FACC

Roundtable Discussion

TAVR: HOW IMPORTANT IS ALTERNATIVE ACCESS?

Direct Aortic, SubclavianMichael J. Reardon, MD, FACC

TransapicalAnson Cheung, MD

DEBATE: Do the Options of Valve in Valve Change My Surgical Valve Selection in Younger and Moderate Risk Patients?: : Yes Anson Cheung, MD

: : No Steven F. Bolling, MD, FACC

: : Rebuttal

Is TAVR Worth It? QOL/Financial Feasibility AnalysisDavid J. Cohen, MD, MSc

TAVR CONTROVERSIES

DEBATE: Stroke: : Overblown Samir Kapadia, MD, FACC

: : A Real and Continued Problem Martyn R. Thomas, MD

DEBATE: Paravalvular Leak: How Big of a Deal is It?: : The Problem Michael J. Mack, MD, FACC

: : Potential Solutions John G. Webb, MD, FACC

CROSSFIRE: Moderate AVR Risk Patients: Is it OK to be Aggressive with TAVR?: : An Interventionalist’s

Perspective Martin B. Leon, MD, FACC

: : A Surgeon’s Perspective Michael J. Reardon, MD, FACC

: : A Neutral Perspective Blase A. Carabello, MD. FACC

DEBATE: Asymptomatic Aortic Stenosis : : Need to be More Aggressive Blase A. Carabello, MD, FACC

: : Need to be Appropriately Conservative?

Maurice E. Sarano, MD

DEBATE: Balloon vs. Self Expanding: : I Prefer the Balloon

Expandable Samir Kapadia, MD, FACC

: : Self Expanding Will Become The Gold Standard

Jeffrey J. Popma, MD, FACC

Judicious Utilization of TAVR Technology: A Balancing ActMartyn R. Thomas, MD

Wrap Up RoundtableModerators: Gregory P. Fontana, MD, FACC Raj Makkar, MD, FACCMichael J. Mack, MD, FACC Martin B. Leon, MD, FACC

Keynote LectureMy Dispassionate and Unbiased Take on TAVR: A Neutral OpinionAnthony DeMaria, MD, MACC

SESSION VII: MITRAL VALVE DISEASEModerators: Gregg W. Stone, MD, FACC Saibal Kar, MD, FACC

Understanding the Pathophysiology of Mitral RegurgitationWilliam A. Zoghbi, MD, FACC

DEBATE: Asymptomatic Severe Mitral Regurgitation Should Be Treated Conservatively: : Pro Robert J. Siegel, MD, FACC

: : Con Maurice E. Sarano, MD

CROSSFIRE: How Should We Treat Functional Mitral Regurgitation?: : Functional Mitral Regurgitation

is a Ventricular Disease and Should be Treated Medically

Blase A. Carabello, MD, FACC

: : Functional Mitral Regurgitation is a Surgical Disease and Should be Treated Surgically

Steven F. Bolling, MD, FACC

: : MitraClip is the Best Treatment for Functional Mitral Regurgitation

Gregg W. Stone, MD, FACC

DEBATE: Degenerative Mitral Regurgitation : : Minimally Invasive Surgery

is the Safest and Most Effective Treatment

W. Randolph Chitwood, Jr., MD, FACC

: : Transcatheter Therapies Will Become The Solution for Most Patients

Ted Feldman, MD, FACC

Surgical Treatment of Complex Degenerative Mitral RegurgitationAlfredo Trento, MD

SESSION VIII: CARDIOEMBOLIC STROKEModerators: Saibal Kar, MD, FACC Gregg W. Stone, MD, FACC

DEBATE: The PFO Chapter Is Closed; The Device Closure is Unethical Outside of Clinical Trials: : Pro Patrick Lyden, MD

: : Con Ted Feldman, MD, FACC

CROSSFIRE: Stroke and Atrial Fibrillation: : Left Atrial Appendage

Occlusion is Safest and at Least as Efficacious as Medical Therapy

Brian K. Whisenant, MD, FACC

: : There is Inadequate Support for the Routine Use of LAA Occlusion

Rita F. Redberg, MD, MSc, FACC

: : Surgical MAZE Procedure and Appendage Exclusion Provides the Most Practical Solution for Atrial Fibrillation

W. Randolph Chitwood, Jr., MD, FACC

Preliminary Scientific Program

September 21 & 22, 2012

Available Courses/Events:

Í 3rd Annual Advances in the Treatment of Heart Failure Symposium

Thursday, September 20, 2012

The Westin South Coast Plaza

686 Anton Boulevard

Costa Mesa, CA 92626

1:45 PM Registration

2:00 – 6:00 PM Presentations

6:00 – 7:00 PM Reception

*Keynote presentation given by ACC

President, William Zoghbi, MD, FACC

Course Directors:

Dipti Itchhaporia, MD, FACC,

and Pravin M. Shah, MD, MACC

Registration: 800-514-4624 or online

at www.Hoag.org/ATHF

All Following Events To Be Held at The Beverly Hills Hotel, Beverly Hills

Í Cardiac Care Associates Educational Session & Networking Reception

Friday September 21, 2012

5:00 – 8:30 PM • Polo Private Room

Please contact the CA ACC Chapter directly at

1-877-460-5880 or at administrator@caacc.org

to make your reservation.

Í “Controversies” Celebration & CA ACC Awards Dinner

Saturday September 22, 2012

6:30 – 9:30 PM • Sunset Foyer/Ballroom

CA ACC Members /Guests –

Complimentary/$40. Controversies

Attendees just $75. Advance Reservations

REQUIRED. Come enjoy a memorable night

featuring camaraderie, décor, delectable

dinner, and and world-class entertainment

by Armando Compean and Texas Brown –

a gift from CA ACC to those that care for

our patients.

Please contact the CA ACC Chapter directly at

1-877-460-5880 or at administrator@caacc.org

to make your reservation.

Other CA ACC Events : (by invitation only or your special request)

Í CA ACC Board of Directors/Council/ Committee Meeting

Sunday September 23, 2012

8:30 AM – 2:00 PM • Sunset Ballroom Elected/Appointed Leaders

Breakfast, Meetings, Lunch. Addressing

all of the hot topics facing Cardiology in

California today.

CALIFORNIA CHAPTER OF THE AMERICAN COLLEGE OF CARDIOLOGY MISSION:

To advocate for accessible, highest quality, cost effective cardiovascular care for Californians.

PROUD PARTNER OF THE

23RD Annual Meeting Satellite Events

Providing Ongoing Education of Cardiologists and Team Members

September 21 & 22, 2012

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

September 21 & 22, 2012 • The Beverly Hills Hotel - Beverly Hills, California

Registration Information$595 Physician/Industry through August 17, 2012$695 Physician/Industry after August 17, 2012$395 Nurse/Resident/Technician through

August 17, 2012$495 Nurse/Resident/Technician after

August 17, 2012$395 ACC National Members$195 California Chapter ACC Members/

Cardiac Care Associates

Registration fees include breaks, lunches, and welcome reception, as well as scientific program materials. Please make checks payable to Promedica International in U.S. dollars drawn on a U.S. bank. Visa, MasterCard, Discover and American Express credit cards are also accepted. Registrations should be faxed, mailed or submitted online at www.promedicacme.com.

To register, please complete the attached form and mail or fax to:

Promedica International 2333 State Street, Suite 203, Carlsbad, CA 92008 Tel: (760) 720-2263, Fax: (760) 720-6263 Lsteigerwald@promedicacme.com

Refunds

All cancellations must be submitted in writing, via facsimile or postal mail. Refunds are subject to a $100 administration charge. Cancellations cannot be accepted over the telephone. Refunds will not be available after August 17, 2012.

Hotel Accommodations

A special room rate of $405 per night plus tax at the celebrated Beverly Hills Hotel has been arranged for program participants. Reserve your room prior to the cutoff date of Thursday, August 30, 2012 by calling 1-800-283-8885, or 1-310-276-2251. Mention your affiliation with the Controversies and Advances in the Treatment of Cardiovascular Disease symposium to receive the special rate.

CME Accreditation and Designation

Promedica International is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Promedica International designates this live activity for a maximum of 19 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provider approved by the California Board of Registered Nursing, Provider #8495 for 19 Contact Hours.

Category 1 CEUs for Perfusionists have been applied for through the American Board of Cardiovascular Perfusion (ABCP).

Activity Evaluation

Evaluation by online questionnaire will address content, presentation, and future educational needs.

Physician/Industry: $595 through August 17, 2012 $695 after August 17, 2012

Nurse/Resident/Technician: $395 through August 17, 2012 $495 after August 17, 2012

ACC National Members: $395

California Chapter ACC Members/Cardiac Care Associates: $195

Please mail or fax to: Promedica International, 2333 State Street, Suite 203, Carlsbad, CA 92008

Tel: (760) 720-2263, Fax: (760) 720-6263, Lsteigerwald@promedicacme.com

All fees in US dollars drawn on US banks:

P Check Enclosed P Visa/MasterCard

P American Express P Discover

Cr'edit Card Number Expiration Date

Signature

First/Last Name P MD PRN PCCP PNP

Institution

Mailing Address

City/State/Zip/Country

Telephone Fax

Email Address Specialty

Visit us at www.promedicacme.com for convenient online registration.

Pro

med

ica

Inte

rnat

ion

al

2333

Sta

te S

tree

t, Su

ite 2

03

Car

lsba

d, C

A 9

200

8P

reso

rt S

tan

dar

d

U.S

. Po

stag

e

Paid

Perm

it 19

48

San

Die

go C

A

WH

AT

TH

EY

’RE

SA

YIN

G:

: : A

n o

uts

tan

din

g p

rogr

am o

n c

utt

ing-

edge

su

bje

cts

pre

sen

ted

in a

man

ner

that

inv

ites

ac

tive

par

tici

pat

ion

.

: : A

wel

l-des

erve

d re

pu

tatio

n fo

r a h

igh

-qu

ality

pro

gram

!

: : E

xcel

len

t pro

gram

that

bri

ngs

car

dio

logy

an

d c

ard

iac

su

rger

y to

geth

er.

: : T

he

pre

sen

tatio

ns

wer

e in

form

ativ

e an

d e

nte

rtai

nin

g.

On

e of

the

best

mee

tings

I’ve

att

end

ed!

: : E

xcep

tion

al fa

culty

, tim

ely

top

ics,

extr

emel

y w

ell o

rgan

ized

.

: : C

onsi

sten

tly g

reat

con

fere

nce

, yea

r aft

er y

ear!

: : A

s al

way

s, th

e “C

ontr

over

sies

” com

mitt

ee p

rese

nte

d th

e

late

st a

nd

gre

ates

t in

car

dio

vasc

ula

r res

earc

h a

nd

tr

eatm

ent i

n a

pro

voca

tive

and

inn

ovat

ive

form

at.

Controversies & Advances IN THE TREATMENT OF CARDIOVASCULAR DISEASE

September 21 & 22, 2012 • The Beverly Hills Hotel - Beverly Hills, California

Co

ntr

ov

ers

ies

&

Ad

va

nce

s

IN T

HE

TR

EA

TM

EN

T O

F C

AR

DIO

VA

SC

UL

AR

DIS

EA

SE

Th

e T

we

lfth

in t

he

Se

rie

s •

Se

pte

mb

er

21

& 2

2, 2

012

T

he

Be

ve

rly

Hil

ls H

ote

l –

Be

ve

rly

Hil

ls, C

ali

forn

ia

23R

D A

nn

ual

Mee

tin

g of

the

Cal

ifor

nia

AC

C